Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2019-05-17 Annual Report
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
AGM/Book Closure
Annual Report Classification · 95% confidence The document is a detailed announcement from Dr. Lal PathLabs Limited dated May 17, 2019, addressed to stock exchanges and referencing compliance with SEBI Listing Regulations. It includes multiple key elements: approval of audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2019; declaration of unmodified audit opinion by Deloitte Haskins & Sells LLP; appointment of an additional director; recommendation of final dividend; and details about the upcoming Annual General Meeting (AGM). The document contains the full Independent Auditors' Report, detailed financial results, and management decisions. The presence of the full audit report and comprehensive financial data for the fiscal year indicates this is the official Annual Report filing rather than a brief announcement or certification. It is not merely a report publication announcement or a certification letter, as it contains substantive financial statements and audit opinions. Therefore, the document fits the definition of an Annual Report (10-K equivalent). FY 2019
2019-05-17 English
Outcome of Board Meeting
Audit Report / Information Classification · 95% confidence The document contains multiple key elements that help classify it accurately. It includes the outcome of a Board Meeting held on May 17, 2019, which covers approval of audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2019. It also mentions the convening of the 25th Annual General Meeting, recommendation of a final dividend, and appointment of an additional director. The document includes an Independent Auditors' Report by Deloitte Haskins & Sells LLP on the audited consolidated financial results for the year ended March 31, 2019, with an unmodified opinion. The presence of detailed audit opinions, financial results, and management approvals indicates this is a comprehensive financial report rather than a mere announcement or certification. The document is lengthy (15,000 characters) and contains substantive financial data and analysis, not just a brief announcement or certification. Therefore, it is best classified as an Annual Report (10-K equivalent) or a comprehensive financial report. However, since it primarily focuses on audited financial results and the audit report, and not the full annual report narrative, the most precise classification is Audit Report / Information (AR). FY 2019
2019-05-17 English
Dividend
Annual Report Classification · 95% confidence The document is a detailed announcement from Dr. Lal PathLabs Limited dated May 17, 2019, addressed to stock exchanges and shareholders. It includes multiple key elements: approval of audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2019; declaration of dividend recommendation; appointment of an additional director; and a declaration confirming the audit report with an unmodified opinion by Deloitte Haskins & Sells LLP. The document contains the full Independent Auditors' Report, detailed financial results, and disclosures about board changes. The presence of comprehensive audited financial statements and the auditor's report indicates this is the actual financial report for the full fiscal year, not just an announcement or certification. The document is lengthy (15,000 characters) and contains substantive financial data and analysis, meeting the criteria for an Annual Report (10-K equivalent). Therefore, the filing type is Annual Report (10-K). FY 2019
2019-05-17 English
Investor Presentation
Investor Presentation Classification · 95% confidence The document is titled as an "Investors Presentation on Audited Financial Results (Standalone and Consolidated) for the Quarter and Financial Year ended March 31, 2019." It is addressed to stock exchanges and mentions sharing the presentation with analysts and investors. The content includes financial highlights, key performance indicators, management commentary, and outlook, typical of an investor presentation. The document length is about 15,000 characters, indicating it is a full presentation rather than a brief announcement. There is no indication that this is a full annual report (10-K) or an earnings release (ER) which are usually more concise and focused on financial results only. The presence of detailed financial tables, management commentary, and outlook sections aligns with the definition of an Investor Presentation (IP). Therefore, the document is best classified as an Investor Presentation (IP).
2019-05-17 English
Press Release
Earnings Release Classification · 95% confidence The document is a press release dated May 17, 2019, announcing the audited financial results (standalone and consolidated) for the quarter and financial year ended March 31, 2019. It includes detailed financial performance highlights such as revenue growth, EBITDA, PBT, PAT, and dividend recommendations. The document is not the full annual report but a summary announcement of financial results. It is longer than 5,000 characters and contains substantive financial data and analysis for the quarter and full year, indicating it is a comprehensive financial report for a period shorter than a full fiscal year (quarter and full year). However, since it is a press release announcing quarterly and annual audited results, it aligns best with an Earnings Release (ER) rather than a full Annual Report (10-K) or Interim Report (IR). The presence of quarterly and full year results in a press release format is typical of an Earnings Release. FY 2019
2019-05-17 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 90% confidence The document is an invitation and intimation of a conference call scheduled for May 17, 2019, to discuss the Q4 and FY19 financial and operating performance of Dr. Lal PathLabs Limited. It includes details about the call, dial-in numbers, and participants but does not contain any actual financial data or results. The document is clearly a notice about the upcoming earnings conference call rather than the transcript or the earnings release itself. Therefore, it fits the category of a Call Transcript (CT) invitation or announcement. However, since it is only an invitation and not the transcript, the best fitting category is Call Transcript (CT) as it relates directly to the conference call content. Confidence is high as the document explicitly states it is a conference call invitation for discussing earnings.
2019-05-14 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.